Cargando…

Low HDL Cholesterol, Metformin Use, and Cancer Risk in Type 2 Diabetes: The Hong Kong Diabetes Registry

OBJECTIVE: The AMP-activated protein kinase (AMPK) pathway is a master regulator in energy metabolism and may be related to cancer. In type 2 diabetes, low HDL cholesterol predicts cancer, whereas metformin usage is associated with reduced cancer risk. Both metformin and apolipoprotein A1 activate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xilin, So, Wing Yee, Ma, Ronald C.W., Kong, Alice P.S., Lee, Heung Man, Yu, Linda W.L., Chow, Chun-Chung, Ozaki, Risa, Ko, Gary T.C., Chan, Juliana C.N.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024352/ https://www.ncbi.nlm.nih.gov/pubmed/20980414 http://dx.doi.org/10.2337/dc10-1509

Ejemplares similares

Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2010)

Low LDL Cholesterol, Albuminuria, and Statins for the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2009)

Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry
por: Kong, Alice PS, et al.
Publicado: (2014)

Additive Interaction of Hyperglycemia and Albuminuria on Risk of Ischemic Stroke in Type 2 Diabetes: Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2008)

Metabolic Syndrome Predicts New Onset of Chronic Kidney Disease in 5,829 Patients With Type 2 Diabetes: A 5-year prospective analysis of the Hong Kong Diabetes Registry
por: Luk, Andrea O.Y., et al.
Publicado: (2008)

Evolution of Diabetes Care in Hong Kong: From the Hong Kong Diabetes Register to JADE-PEARL Program to RAMP and PEP Program
por: Ng, Ivy H.Y., et al.
Publicado: (2018)

Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort study
por: Wu, Hongjiang, et al.
Publicado: (2021)

The problem of obesity among adolescents in Hong Kong: a comparison using various diagnostic criteria
por: Ko, Gary TC, et al.
Publicado: (2008)

Validation of Methods to Control for Immortal Time Bias in a Pharmacoepidemiologic Analysis of Renin–Angiotensin System Inhibitors in Type 2 Diabetes
por: Yang, Xilin, et al.
Publicado: (2014)

Incident cardiovascular-kidney disease, diabetic ketoacidosis, hypoglycaemia and mortality in adult-onset type 1 diabetes: a population-based retrospective cohort study in Hong Kong
por: Fan, Yingnan, et al.
Publicado: (2023)

The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry
por: Chan, Juliana C. N., et al.
Publicado: (2011)

Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank
por: Jiang, Guozhi, et al.
Publicado: (2020)

The role of age on the risk relationship between prediabetes and major morbidities and mortality: Analysis of the Hong Kong diabetes surveillance database of 2 million Chinese adults
por: Zhang, Xinge, et al.
Publicado: (2022)

Additive Interaction Between the Renin-Angiotensin System and Lipid Metabolism for Cancer in Type 2 Diabetes
por: Yang, Xilin, et al.
Publicado: (2009)

Glucose-lowering drug use, glycemic outcomes, and severe hypoglycemia: 18-Year trends in 0·9 million adults with Diabetes in Hong Kong (2002–2019)
por: Yang, Aimin, et al.
Publicado: (2022)

Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
por: Kong, Alice PS, et al.
Publicado: (2014)

Association of self-reported recurrent mild hypoglycemia with incident cardiovascular disease and all-cause mortality in patients with type 2 diabetes: Prospective analysis of the Joint Asia Diabetes Evaluation Registry
por: Luk, Andrea On Yan, et al.
Publicado: (2016)

Depressive Symptoms, Co-Morbidities, and Glycemic Control in Hong Kong Chinese Elderly Patients With Type 2 Diabetes Mellitus
por: Fung, Annie C. H., et al.
Publicado: (2018)

SARS-related Perceptions in Hong Kong
por: Lau, Joseph T.F., et al.
Publicado: (2005)

High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank
por: Jin, Qiao, et al.
Publicado: (2022)

Trends in diabetes-related complications in Hong Kong, 2001–2016: a retrospective cohort study
por: Wu, Hongjiang, et al.
Publicado: (2020)

Hong Kong Chinese school children with elevated urine melamine levels: A prospective follow up study
por: Kong, Alice PS, et al.
Publicado: (2011)

Team-Based Diabetes Care in Ontario and Hong Kong: a Comparative Review
por: Ke, Calvin, et al.
Publicado: (2023)

Molecular and clinical characterization of citrin deficiency in a cohort of Chinese patients in Hong Kong
por: Chong, S.C., et al.
Publicado: (2018)

Diabetes-Related Distress and Physical and Psychological Health in Chinese Type 2 Diabetic Patients
por: Ting, Rose Z.W., et al.
Publicado: (2011)

Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study
por: Luk, Andrea O. Y., et al.
Publicado: (2020)

Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients – the Hong Kong diabetes registry
por: Yang, Xilin, et al.
Publicado: (2007)

The growth pattern and fuel life cycle analysis of the electricity consumption of Hong Kong
por: To, W.M., et al.
Publicado: (2012)

Predictors and moderators of COVID-19 pandemic fatigue in Hong Kong
por: Lai, Daniel W.L., et al.
Publicado: (2023)

Development of price models for architectural and environmental quality for residential developments in Hong Kong
por: Fung, Y.W., et al.
Publicado: (2014)

Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysis
por: Lim, Lee-Ling, et al.
Publicado: (2020)

Thoracic surgery in Hong Kong
por: Chang, Aliss T. C., et al.
Publicado: (2022)

Respiratory Infections during SARS Outbreak, Hong Kong, 2003
por: Lo, Janice Y.C., et al.
Publicado: (2005)

Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001–2016: a retrospective study
por: Luk, Andrea O. Y., et al.
Publicado: (2020)

Genotype Distribution and Sequence Variation of Hepatitis E Virus, Hong Kong
por: Lam, Wai-Yip, et al.
Publicado: (2009)

Melioidosis in Hong Kong
por: Lui, Grace, et al.
Publicado: (2018)

Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study
por: Ting, Rose ZW, et al.
Publicado: (2010)

Comment on: Suissa and Azoulay. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Yang, Xilin, et al.
Publicado: (2013)

SARS Transmission, Risk Factors, and Prevention in Hong Kong
por: Lau, Joseph T.F., et al.
Publicado: (2004)

Triglycerides and HDL Cholesterol: Stars or second leads in diabetes?
por: Bitzur, Rafael, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_av237vdh1p0qmuvfns1hfbrr0n